Zydus Lifesciences Ltd. (ZYDUSLIFE): Zydus Lifesciences Share Price rises 3.26% as stock gains today
- August 27, 2026
- Posted by: Harsh Piplani
- Category: News
Zydus Lifesciences Share Price rose to Rs 1,185.40, up 3.26% from the previous close of Rs 1,147.95. The company’s market capitalisation stands at Rs 1,12,717.93 Cr, placing today’s move in a large listed healthcare business context. The supplied data confirms a same-day share price gain and a higher intraday range, but it does not establish a company-specific catalyst. For readers tracking Zydus Lifesciences Share Price Today, the key numbers are the Rs 37.45 rise, the day open at Rs 1,160, the day low at Rs 1,142.50 and the day high at Rs 1,194.20. Univest is monitoring the move alongside valuation, sector comparison and peer benchmarks so that Zydus Lifesciences Stock News can be read with the full market backdrop.
Zydus Lifesciences Share Price is in focus after the stock rose 3.26% on the day to Rs 1,185.40, adding Rs 37.45 over the previous close of Rs 1,147.95. The company’s market capitalisation of Rs 1,12,717.93 Cr keeps the move relevant for investors following large listed healthcare names on NSE and BSE. Today’s range stretched from Rs 1,142.50 to Rs 1,194.20, while the open was Rs 1,160.00. The supplied data confirms the price event but does not establish a company-specific catalyst, so the move should be read through the lens of price action, valuation, and industry context rather than a stated trigger. Univest places Zydus Lifesciences Stock News in that framework, with the current market update useful for anyone searching Zydus Lifesciences Share Price Today, Zydus Lifesciences Share Price Update, or Zydus Lifesciences Stock Analysis.
Zydus Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,185.4 |
| Previous Close | Rs 1,147.95 |
| Today's Move | Rs 37.45 (+3.26%) |
| Open | Rs 1,160 |
| High | Rs 1,194.2 |
| Low | Rs 1,142.5 |
| Turnover | Rs 36.96 crore |
| Market Capitalisation | Rs 1,12,717.93 crore |
| Market Cap Category | Large Cap |
Zydus Lifesciences Ltd. (ZYDUSLIFE) rose to Rs 1,185.4 from the previous close of Rs 1,147.95, a move of Rs 37.45 or 3.26%. The stock opened at Rs 1,160, reached a high of Rs 1,194.2, recorded a low of Rs 1,142.5.
The session showed a clear same-day share price gain. Zydus Lifesciences opened at Rs 1,160.00, moved between Rs 1,142.50 and Rs 1,194.20, and closed the day at Rs 1,185.40. That leaves the stock Rs 37.45 above the previous close of Rs 1,147.95. The turnover stood at Rs 36.96 Cr, which is a traded-value figure and should be read only as a factual market metric. In plain terms, the data shows Zydus Lifesciences rising today, and it is one of the more notable stocks in news within the healthcare space. The numbers show where the stock traded during the day, but they do not identify why the move happened. For readers following Zydus Lifesciences Share Price Live, the useful takeaway is the combination of a higher close, a wider intraday band and a positive percentage change.
Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,12,717.93 crore |
| P/E Ratio | 25.37x |
| P/B Ratio | 4.25x |
| ROE | 19.69% |
| ROCE | 21.39% |
| EPS | Rs 45.24 |
| Book Value Per Share | Rs 270.31 |
| Dividend Yield | 0.09% |
Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 25.37x, P/B 4.25x, ROE 19.69%, ROCE 21.39%. These figures provide context only and are not a buy or sell signal.
Zydus Lifesciences Ltd. has a market capitalisation of Rs 112717.93 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.37x, P/B at 4.25x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.58x, median ROE of 11.87%, median ROCE of 13.88%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.37x |
| Benchmark Median P/E | 30.58x |
| Benchmark Average P/E | 47.16x |
| Benchmark P/E Range | 3.19x to 671.51x |
| Company P/B Ratio | 4.25x |
| Benchmark Median P/B | 2.76x |
| Company ROE | 19.69% |
| Benchmark Median ROE | 11.87% |
| Company ROCE | 21.39% |
| Benchmark Median ROCE | 13.88% |
| Company Market Capitalisation | Rs 1,12,717.93 crore |
| Benchmark Median Market Cap | Rs 644.16 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 25.37x, which is below the benchmark median of 30.58x, a difference of -17.04%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.87%, a difference of +65.88%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.88%, a difference of +54.11%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,59,952.51 | 37.71 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,30,426.73 | 81.82 | 13.55 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,87,140.99 | 85.25 | 20.71 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,14,715.15 | 33.76 | 3.24 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,00,768.23 | 93.3 | 18.09 | 18.31 | 18.2 |
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 25.37x compared with the displayed peer median of 81.82x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,12,717.93 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Zydus Lifesciences
- Zydus Lifesciences Share Price rose 3.26% today to Rs 1,185.40 from Rs 1,147.95.
- The day move added Rs 37.45, with the session ranging from Rs 1,142.50 to Rs 1,194.20.
- Market capitalisation stands at Rs 1,12,717.93 Cr, keeping the stock relevant in healthcare market updates.
- P/E of 25.37 is below the same-industry median of 30.58, while ROE of 19.69 is above 11.87.
- P/B of 4.25, ROCE of 21.39, EPS of 45.24 and book value of Rs 270.31 add valuation context to Zydus Lifesciences Share Price.
About Zydus Lifesciences
Zydus Lifesciences Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s listed profile on NSE and BSE is followed closely because it sits among established pharmaceutical names with a market cap of Rs 1,12,717.93 Cr. The supplied data does not break out business segments, revenue mix or product lines, so the company overview here stays limited to verified facts. What can be said with confidence is that Zydus Lifesciences Share Price reflects a business with meaningful scale, a published earnings base and return ratios that are above the industry median. For readers scanning Zydus Lifesciences Stock News, the company is best understood as a large healthcare participant whose current market update must be read alongside its fundamental metrics, peer set and sector benchmark rather than as a standalone price move.
Track Zydus Lifesciences Share Price on Univest
Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Zydus Lifesciences Share Price on Univest for live market updates, key fundamental ratios, shareholding pattern views, 52-week levels and broader market insights. Univest also presents Zydus Lifesciences Stock Analysis in a format that helps connect share price updates with valuation, sector comparison and company-specific data. For anyone following Zydus Lifesciences Share Price Today or Zydus Lifesciences Latest News, the platform keeps the numbers together in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Zydus Lifesciences Share Price rise today?
Ans. The supplied data shows Zydus Lifesciences Share Price rose 3.26% to Rs 1,185.40, but it does not establish a company-specific catalyst. The move is confirmed by the day’s close, open, low and high.
What is the current Zydus Lifesciences Share Price?
Ans. Zydus Lifesciences Share Price stands at Rs 1,185.40 in the latest session. It finished Rs 37.45 above the previous close of Rs 1,147.95, with turnover recorded at Rs 36.96 Cr.
How much did Zydus Lifesciences stock gain today?
Ans. Zydus Lifesciences gained Rs 37.45 on the day, which equals a 3.26% rise from the previous close. The intraday range was Rs 1,142.50 to Rs 1,194.20. The previous close was Rs 1,147.95.
What is Zydus Lifesciences market capitalisation?
Ans. Zydus Lifesciences has a market capitalisation of Rs 1,12,717.93 Cr. That size places the company well above the industry median market cap of Rs 644.16 Cr in the same-industry dataset.
Is Zydus Lifesciences expensive compared with peers?
Ans. On P/E, Zydus Lifesciences at 25.37 is below the industry median of 30.58 and below several peers. Its P/B of 4.25 sits above the industry median of 2.76. Comparable listed companies include Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent.
What do Zydus Lifesciences EPS and book value show?
Ans. EPS of 45.24 shows earnings attributable to each share, while book value of Rs 270.31 reflects accounting net worth per share. Together they help frame Zydus Lifesciences Share Price against fundamentals.
How does Zydus Lifesciences compare with healthcare peers?
Ans. Zydus Lifesciences has a lower P/E than Sun Pharmaceutical, Divi's Laboratories, Torrent Pharmaceuticals, Cipla and Laurus Labs. Its ROE and ROCE also compare favourably with several names in the peer set.
Can investors track Zydus Lifesciences Share Price on Univest?
Ans. Yes, Univest tracks Zydus Lifesciences Share Price along with key ratios, shareholding pattern views, 52-week levels and market insights. That makes it easier to follow Zydus Lifesciences Stock News in one place.
